Neoplasms, Plasma Cell
Showing 1 - 25 of >10,000
Multiple Myeloma, Primary Plasma Cell Leukemia Trial in Shanghai (Experimental: CAR-T cells Infusion)
Not yet recruiting
- Multiple Myeloma
- Primary Plasma Cell Leukemia
- Experimental: CAR-T cells Infusion
-
Shanghai, ChinaShanghai Changzheng Hospital
Apr 20, 2023
Multiple Myeloma, Plasma Cell Leukemia Trial in Suzhou (CT0594CP)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- CT0594CP
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital, Soochow University
Apr 18, 2023
Relapsed and/or Refractory Multiple Myeloma, Plasma Cell Leukemia in Relapse Trial in Shanghai (Biological)
Recruiting
- Relapsed and/or Refractory Multiple Myeloma
- Plasma Cell Leukemia in Relapse
- Biological
-
Shanghai, Shanghai, ChinaShanghai Tongji Hospital
May 29, 2023
Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia
- CAR-T (CAR-GPRC5D)
- (no location specified)
Feb 26, 2023
Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)
Recruiting
- Multiple Myeloma
- Plasma Cell Leukemia
- Human BCMA targeted CAR-NK cells injection
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Sep 13, 2023
Myeloma Multiple Trial (Off Drug Surveillance)
Not yet recruiting
- Myeloma Multiple
- Off Drug Surveillance
- (no location specified)
Jun 27, 2023
Examination of Trends in Multiple Myeloma Trial Patient
Not yet recruiting
- Multiple Myeloma
- (no location specified)
May 19, 2023
Multiple Myeloma Prognostic Indices
Recruiting
- Multiple Myeloma
- Hematologic Diseases
- blood viscosity , albumin / fibrinogen ratio and red cell distribution
-
Assiut, EgyptAssiut University hospital
Oct 17, 2023
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Relapsed/Refractory Multiple Myeloma Trial in Philadelphia (Cevostamab)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Apr 7, 2023
Multiple Myeloma, Fatigue, Pain Trial (Auricular Acupuncture)
Not yet recruiting
- Multiple Myeloma
- +3 more
- Auricular Acupuncture
- (no location specified)
Mar 7, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Myeloma Multiple Trial in Chia (Dasatinib 100 MG)
Not yet recruiting
- Myeloma Multiple
- Dasatinib 100 MG
-
Chia, Cundinamarca, ColombiaCAIMED
Jul 12, 2023
Multiple Myeloma Trial in Los Angeles (Penguin Cold Cap)
Recruiting
- Multiple Myeloma
- Penguin Cold Cap
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 27, 2023
Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)
Not yet recruiting
- Multiple Myeloma
- Iberdomide
- Daratumumab/rHuPH20 Co-formulation
- (no location specified)
Oct 25, 2023
Real-World Mapping Antithrombotic Regimens in MM Patients on
Not yet recruiting
- Multiple Myeloma
- Diagnosis
- (no location specified)
Aug 31, 2023
Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Lymphoma
- Multiple Myeloma
- pegylated recombinant human granulocyte-colony stimulating factor
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 23, 2023
Multiple Myeloma Trial in São Paulo (Single-dose involved-site radiotherapy)
Recruiting
- Multiple Myeloma
- Single-dose involved-site radiotherapy
-
São Paulo, Sao Paulo, BrazilUniversity of Sao Paulo
Aug 9, 2023
Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)
Recruiting
- Multiple Myeloma
- Total Marrow irradiation,TMI
- Autologous hematopoietic stem cell transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 24, 2023
Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Recruiting
- Plasma Cell Myeloma
- Biospecimen Collection
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 26, 2023
Learn How Triple Class Refractory Multiple Myeloma Are Treated
Not yet recruiting
- Relapse Multiple Myeloma
- Refractory Multiple Myeloma
- (no location specified)
Feb 15, 2023
Multiple Myeloma Trial in Boston (THRIVE-M)
Not yet recruiting
- Multiple Myeloma
- THRIVE-M
-
Boston, MassachusettsMassachusetts General Hospital
Oct 2, 2023